How midkine helps tumours evade immunotherapy
Of Interest
Mobile App Cuts Skin Cancer Referrals in Half, British Trial Shows
The Map My Mole app provides patients with a small lens attachment for their phones to capture high-quality images of concerning skin spots. These images are then uploaded for assessment by consultants.
Anti–LAG-3/Anti–PD-1 Combo Demonstrates Sustained Efficacy in Melanoma
Meredith McKean, MD, MPH, director of melanoma and skin cancer research at Sarah Cannon Research Institute, discusses the background and goals from the recent long-term follow-up of a phase 1 study (NCT03005782) evaluating the combination of fianlimab, an anti–LAG-3 agent, and cemiplimab (Libtayo), an anti–PD-1 agent, in patients with advanced melanoma.
A novel radiosurgical platform to treat a case of uveal melanoma
The ZAP-X system is described by researchers as a “dedicated, self-contained, and self-shielded surgical robot" designed for performing stereotactic surgery (SRS) on the brain, head, and neck. This technology was utilized to treat a patient with uveal melanoma.